1,472
Views
43
CrossRef citations to date
0
Altmetric
Reviews

Drugs for insomnia

, PhD
Pages 299-317 | Published online: 11 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Minghui Tang, Yong Ai, Ni Song, Lin Geng, Lu Ren, Siyang Zhu, Yan Ai, Shaochun Cai, Zhiting Zhang, Lanyue Zhang & Tingang He. (2023) Chemical Composition and Hypnotic Effect of Picea mariana Essential Oils. Journal of Essential Oil Bearing Plants 26:2, pages 362-377.
Read now
Oliviero Bruni, Marco Angriman, Maria Grazia Melegari & Raffaele Ferri. (2019) Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders. Expert Opinion on Pharmacotherapy 20:18, pages 2257-2271.
Read now

Articles from other publishers (41)

Yong Ai, Minghui Tang, Xian Xu, Siyang Zhu, Baoshan Rong, Xiaomin Zheng, Ni Song, Jian He, Lanyue Zhang & Tinggang He. (2023) Volatile Oil from Magnolia sieboldii Improve Neurotransmitter Disturbance and Enhance the Sleep-Promoting Effect in p-Chlorophenylalanine-Induced Sleep-Deprived Mice. Revista Brasileira de Farmacognosia 33:6, pages 1303-1308.
Crossref
Luo-Xuan Wang, Qian Zhao, Yang Zhang, Rui Xue, Shuo Li, Ying Li, Ji-Jun Yu, Jing-Cao Li & You-Zhi Zhang. (2023) Network pharmacology and pharmacological evaluation for deciphering novel indication of Sishen Wan in insomnia treatment. Phytomedicine 108, pages 154500.
Crossref
S. V. Orlova, E. A. Nikitina, N. V. Balashova, Yu. A. Pigareva, E. V. Ankvab & T. I. Khadzhimuratova. (2022) The role of exogenous melatonin in the regulation of sleep. Medical alphabet:25, pages 26-33.
Crossref
Wojciech Ziemichód, Karolina Grabowska, Antonina Kurowska & Grażyna Biała. (2022) A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia. Molecules 27:18, pages 6041.
Crossref
M.F. Vecchierini, U. Kilic-Huck & M.A. Quera-Salva. (2021) La mélatonine (MEL) et son utilisation dans les pathologies neurologiques et l’insomnie : recommandations de la Société française de recherche et de médecine du sommeil (SFRMS). Médecine du Sommeil 18:2, pages 70-89.
Crossref
M.F. Vecchierini, U. Kilic-Huck & M.A. Quera-Salva. (2021) Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS). Revue Neurologique 177:3, pages 245-259.
Crossref
Junsik Lim, Kanghyun Leem & Taeyeon Kim. (2021) Sleep-promoting and Anti-anxiety Effects of Shihogayonggolmoryo-tang in Mice. Journal of Physiology & Pathology in Korean Medicine 35:1, pages 8-14.
Crossref
Yuanming Li, Jing Zhang, Jiale Wan, Anru Liu & Jinhao Sun. (2020) Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease. Biomedicine & Pharmacotherapy 132, pages 110887.
Crossref
Zoe Claire Juneau, Jamie M. Stonemetz, Ryan F. Toma, Debra R. Possidente, R. Conor Heins & Christopher G. Vecsey. (2019) Optogenetic activation of short neuropeptide F (sNPF) neurons induces sleep in Drosophila melanogaster. Physiology & Behavior 206, pages 143-156.
Crossref
Aisha S. Shariq, Joshua D. Rosenblat, Asem Alageel, Rodrigo B. Mansur, Carola Rong, Roger C. Ho, Renee-Marie Ragguett, Zihang Pan, Elisa Brietzke & Roger S. McIntyre. (2019) Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 92, pages 1-7.
Crossref
Dool-Ri Oh, Yujin Kim, Ara Jo, Eun Jin Choi, Kyo-Nyeo Oh, Jaeyong Kim, Huwon Kang, Young Ran Kim & Chul yung Choi. (2019) Sedative and hypnotic effects of Vaccinium bracteatum Thunb. through the regulation of serotonegic and GABAA-ergic systems: Involvement of 5-HT1A receptor agonistic activity. Biomedicine & Pharmacotherapy 109, pages 2218-2227.
Crossref
Nava Zisapel. (2018) New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. British Journal of Pharmacology 175:16, pages 3190-3199.
Crossref
Oliviero Bruni, Marco Angriman, Fabrizio Calisti, Alessandro Comandini, Giovanna Esposito, Samuele Cortese & Raffaele Ferri. (2017) Practitioner Review: Treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities. Journal of Child Psychology and Psychiatry 59:5, pages 489-508.
Crossref
Helen M. Stallman, Mark Kohler & Jason White. (2018) Medication induced sleepwalking: A systematic review. Sleep Medicine Reviews 37, pages 105-113.
Crossref
I. G. Sil’kis. (2018) A Neurochemical Approach to the Search for Drugs for the Treatment of Symptoms of Alzheimer’s Disease. Neurochemical Journal 12:1, pages 15-22.
Crossref
Daniel L. Krinsky, Stefanie P. Ferreri, Brian Hemstreet, Anne L. Hume, Gail D. Newton, Carol J. Rollins & Karen J. TietzeSarah T. Melton & Cynthia K. Kirkwood. 2017. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 19th Edition. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 19th Edition.
Zhihao Liu, Yakun Yang, Li Sheng & Yan Li. (2017) Interspecies Variation of In Vitro Stability and Metabolic Diversity of YZG-331, a Promising Sedative-Hypnotic Compound. Frontiers in Pharmacology 8.
Crossref
Oliviero Bruni & Marco Angriman. 2017. Sleep Disorders in Children. Sleep Disorders in Children 155 184 .
Mei Hong Qiu, Michael C. Chen, Patrick M. Fuller & Jun Lu. (2016) Stimulation of the Pontine Parabrachial Nucleus Promotes Wakefulness via Extra-thalamic Forebrain Circuit Nodes. Current Biology 26:17, pages 2301-2312.
Crossref
Lee Taylor, Bryna C. R. Chrismas, Ben Dascombe, Karim Chamari & Peter M. Fowler. (2016) Sleep Medication and Athletic Performance—The Evidence for Practitioners and Future Research Directions. Frontiers in Physiology 7.
Crossref
Anna B. Fishbein, Olivia Vitaterna, Isabel M. Haugh, Aakash A. Bavishi, Phyllis C. Zee, Fred W. Turek, Stephen H. Sheldon, Jonathan I. Silverberg & Amy S. Paller. (2015) Nocturnal eczema: Review of sleep and circadian rhythms in children with atopic dermatitis and future research directions. Journal of Allergy and Clinical Immunology 136:5, pages 1170-1177.
Crossref
Madura B. A. Kumar, Yuan Gao, Wei Shen & Lizhong He. (2015) Valorisation of protein waste: An enzymatic approach to make commodity chemicals. Frontiers of Chemical Science and Engineering 9:3, pages 295-307.
Crossref
Yan Ma, Ming Dong, Carol Mita, Shuchen Sun, Chung-Kang Peng & Albert C. Yang. (2015) Publication analysis on insomnia: how much has been done in the past two decades?. Sleep Medicine 16:7, pages 820-826.
Crossref
Yaxin Zheng, Jiming Wu, Xuesong Feng, Ying Jia, Jian Huang, Zhihui Hao, Songyan Zhao & Jinhui Wang. (2015) In silico Analysis and Experimental Validation of Lignan Extracts from Kadsura longipedunculata for Potential 5-HT1AR Agonists. PLOS ONE 10:6, pages e0130055.
Crossref
Julieta Scalo, Pooja Desai & Karen Rascati. (2014) Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample. Quality of Life Research 24:5, pages 1223-1233.
Crossref
Hilde Lavreysen, Abdellah Ahnaou, Wilhelmus Drinkenburg, Xavier Langlois, Claire Mackie, Stefan Pype, Robert Lütjens, Emmanuel Le Poul, Andrés A. Trabanco & José María Cid Nuñez. (2015) Pharmacological and pharmacokinetic properties of JNJ-40411813, a positive allosteric modulator of the mGlu2 receptor. Pharmacology Research & Perspectives 3:1, pages e00096.
Crossref
Lin-lin Hu, Xin Zhang, Wen-juan Liu, Mei Li & Yong-hua Zhang. (2015) Suan Zao Ren Tang in Combination with Zhi Zi Chi Tang as a Treatment Protocol for Insomniacs with Anxiety: A Randomized Parallel-Controlled Trial . Evidence-Based Complementary and Alternative Medicine 2015, pages 1-7.
Crossref
Gloria Martin & Antonio Guglietta. 2015. Drug Treatment of Sleep Disorders. Drug Treatment of Sleep Disorders 85 107 .
Michael Thorpy. 2015. Drug Treatment of Sleep Disorders. Drug Treatment of Sleep Disorders 71 83 .
Y. Shi, J.W. Dong, L.N. Tang, R.X. Kang, J.G. Shi & J.J. Zhang. (2014) N6-(3-methoxyl-4-hydroxybenzyl) adenine riboside induces sedative and hypnotic effects via GAD enzyme activation in mice. Pharmacology Biochemistry and Behavior 126, pages 146-151.
Crossref
James MacFarlane, Charles M. Morin & Jacques Montplaisir. (2014) Hypnotics in Insomnia: The Experience of Zolpidem. Clinical Therapeutics 36:11, pages 1676-1701.
Crossref
Mellar P. Davis & Harold W. Goforth. (2014) Long-term and Short-term Effects of Insomnia in Cancer and Effective Interventions. The Cancer Journal 20:5, pages 330-344.
Crossref
Jennifer Kelly. (2014) Insomnia treatment for the medically ill hospitalized patient. Mental Health Clinician 4:2, pages 82-90.
Crossref
Chandra K. Cooper. (2014) Orexin receptor antagonists: Novel hypnotic agents. Mental Health Clinician 4:2, pages 73-77.
Crossref
William Vaughn McCallJulieta ScaloKaren Rascati. 2014. Advances in the Management of Primary and Secondary Insomnia. Advances in the Management of Primary and Secondary Insomnia 72 90 .
William Vaughn McCallJulieta ScaloKaren Rascati. 2014. Advances in the Management of Primary and Secondary Insomnia. Advances in the Management of Primary and Secondary Insomnia 32 54 .
Judith A. Owens. 2014. Principles and Practice of Pediatric Sleep Medicine. Principles and Practice of Pediatric Sleep Medicine 53 61 .
Jasper Dingemanse, Petra Hoever, Matthias Hoch, Alexander Treiber, Winfried Wagner-Redeker, Tommaso Miraval, Gérard Hopfgartner & Kasra Shakeri-Nejad. (2013) Elucidation of the Metabolic Pathways and the Resulting Multiple Metabolites of Almorexant, a Dual Orexin Receptor Antagonist, in Humans. Drug Metabolism and Disposition 41:5, pages 1046-1059.
Crossref
Katherine A. Lyseng-Williamson. (2013) Melatonin prolonged release: a guide to its use in the treatment of insomnia in patients aged ≥55 years. Drugs & Therapy Perspectives 29:5, pages 125-129.
Crossref
Katherine A. Lyseng-Williamson. (2012) Melatonin Prolonged Release. Drugs & Aging 29:11, pages 911-923.
Crossref
Miranda Varrasse McPhillips, Junxin Li, Nalaka S. Gooneratne, Subhash Aryal & Nancy Hodgson. (2022) A Randomized Controlled Trial to Test a Behavioral Sleep Intervention to Improve Insomnia Symptoms in Older Adults with Mild Cognitive Impairment: Multicomponent Behavioral Sleep Intervention (MBSI) Protocol. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.